Aurinia Pharmaceuticals Q3 Earnings Flat, Revenue Rises; 2026 Revenue Outlook Raised

08:29 AM EDT, 10/30/2026 (MT Newswires) -- Aurinia Pharmaceuticals (AUPH) reported Q3 earnings Friday of $0.23 per diluted share, unchanged from a year earlier. An analyst polled by FactSet expected $0.22. Total revenue for the quarter ended Sept. 30 was $83.7 million, up from $73.5 million a year earlier. An analyst polled by FactSet expected $83.6 million. The company raised its 2026 total revenue guidance to a range of $325 million to $330 million versus a range of $315 million to $325 million previously. Analysts polled by FactSet expect $330.3 million. Aurinia's shares were down 3.4% in premarket activity.